T1	Participants 78 91	septic shock.
T2	Participants 219 231	older people
T3	Participants 627 649	septic shock patients.
T4	Participants 767 880	Patients with septic shock who were enrolled in the placebo limb of the North American Sepsis Trial (NORASEPT II)
T5	Participants 998 1099	Nine hundred and thirty patients presenting to hospital within 12 hours of the onset of septic shock.
T6	Participants 1341 1549	population was broken down into five age groups as follows: less than 50 years (group one), 50 to 64 years (group two), 65 to 74 years (group three), 75 to 84 years (group four), and 85 or older (group five).
T7	Participants 1666 1679	930 patients.
T8	Participants 1684 1751	patients' mean age (+/- SD) was 59 +/- 17 years (range, 18 to 102).
T9	Participants 1763 1868	280 patients in group one, 242 in group two, 210 in group three, 150 in group four, and 48 in group five.
